Objective To examine the role of iron and zinc in arsenic excretion and metabolism in children. Study design An analysis of urinary arsenic (UAs) concentrations from a double-blind randomized trial originally testing the efficacy of iron and zinc for lowering blood lead levels in children. A 2 × 2 factorial design was used, with children randomized individually, stratified by sex and classroom, to receive 30 mg ferrous fumarate (n = 148), 30 mg zinc oxide (n = 144), iron and zinc together (n = 148), or placebo (n = 151). Of the 602 children enrolled, 527 completed the 6-month treatment, and 485 had both baseline and final UAs values. The baseline total UAs concentration ranged from 3.2 to 215.9 µg/L.
likewise found no association between iron and zinc intake and urinary arsenic (UAs) concentration in individuals from West Bengal. There are little available data in children, but a recent study found associations between ID and lower %MMA, but slightly higher %DMA. 22 Several animal studies have evaluated the effects of iron and zinc supplementation on arsenic exposure and toxicity, [23] [24] [25] [26] and have suggested an effect on arsenic accumulation.
By leveraging data from Mexican school children who had participated in an iron and zinc supplementation trial, we had the unique opportunity to clarify potential links among children's micronutrient status, supplementation, and arsenic exposure and metabolism.
Methods
This study was a secondary analysis of a double-blind randomized trial of iron and zinc supplementation conducted in 2000-2001 among Mexican schoolchildren to test the efficacy of micronutrients in lowering children's BLL. The design and main findings from that trial have been reported elsewhere. [4] [5] [6] In brief, all first-grade children (aged 6-7 years) attending 9 public elementary schools located in the vicinity of a metal foundry were invited to participate. Arsenic exposure likely occurred from drinking water, given the elevated levels of water arsenic detected in this region. 27 Children whose parents provided consent to participate in the study were assessed at baseline for total UAs, iAs, MMA, DMA, BLL, serum ferritin, and serum zinc concentrations. One child with a BLL ≥45 µg/dL was excluded; no children were excluded owing to hemoglobin (Hb) <9 g/dL.
Participants were randomized individually, stratified by sex and classroom, to receive 1 of 4 treatments: only iron (30 mg/ day of ferrous fumarate), only zinc (30 mg/day of zinc oxide), iron plus zinc (30 mg/day of each), or placebo. The participants and researchers were blinded to the formulation and treatment assignments. Each child received the supplement daily at school. Parents were provided with an adequate supply of the supplement for extended absences and during summer vacation. Assessments of UAs metabolites and other biochemical and anthropometric measurements were repeated after 6 months of supplementation.
Ethics approval for all aspects of the randomized trial was obtained from the Human Research Committees at the Johns Hopkins Bloomberg School of Public Health and the Mexican National Institute of Medical Sciences and Nutrition.
Fasting blood draws for measurements of biochemical indicators and anthropometric measurements were performed at each school. After the blood draws, the children were given snacks. Children also provided first morning urine samples. The samples were kept on ice and later stored at −70°C at the University of Juarez at Durango. Information on family socioeconomic status (SES) was obtained via a self-administered parental questionnaire.
For arsenic analysis, stored urine samples were thawed and warmed to 37°C. Samples were then digested with HCl at 80°C for 5 hours to release methylated compounds of arsenic. 28 IAs, MMA, and DMA were measured by hydride generation coupled with atomic absorption spectroscopy (AAnalyst 3100; PerkinElmer, Waltham, Massachusetts) following published protocol, 29 with coefficients of variation of 1%-9%. Arsenic analysis was carried out at the Center for Research and Advanced Studies, National Polytechnic Institute, Mexico City. The laboratory personnel were blind to treatment allocation. Values for %iAS, %MMA, and %DMA in urine were calculated based on the proportion of these species relative to UAs.
Hb was measured at the time of the blood draw in a drop of venous blood using a portable hemoglobinometer (HemoCue; Ängelholm, Sweden). Serum ferritin concentration was measured via an immunoradiometric assay using a commercially available kit (Coat-A-Count Ferritin IRMA; DPC, Los Angeles, California). Serum zinc level concentration was measured by atomic absorption spectrometry at the University of Queretaro. Anemia was defined as Hb <12.4 g/dL (altitude-adjusted cutoff value for this age group), iron deficiency (ID) was defined as serum ferritin <12 µg/L, and zinc deficiency was defined as serum zinc <65 µg/dL.
Although water arsenic concentrations were not measured at the individual household level, arsenic concentrations in water were available for the study period (1999, 2000/2001, and 2002) for the participating schools from the Torreón Municipal System of Water Administration (G.G. Vargas, personal communication). Because drinking water to private homes is supplied from the same source, we assumed that the school concentrations approximated household exposures.
Statistical Analyses
The children were classified according to tertiles of Hb, serum ferritin, and serum zinc concentrations. These tertiles were modeled in ordinary least squares regressions as independent predictors of UAs, %iAs, %MMA, and %DMA. In addition, ID, anemia, and zinc deficiency were tested as predictors of UAs concentration. All regressions were adjusted for age (continuous variable), sex, body mass index (BMI; continuous), years living in Torreón (continuous), school, and family SES. We adjusted the models for BMI to account for any differences in children's ability to methylate arsenic based on body size or growth. It is important to note that the results did not differ when BMI-for-age z-scores were entered into the models instead of BMI. SES was estimated from the ownership of "luxury" items, such as automobile, computer, and video cassette recorder, and entered into regression models as a categorical variable. These covariates were chosen based on the literature and biological plausibility.
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Main Effects of Iron and Zinc Supplementation on Arsenic Concentrations
We initially compared the distributions of various baseline characteristics among the 4 supplementation groups using 1-way ANOVA and c 2 statistics. With the 2 × 2 factorial design, we tested the main effects of iron and zinc supplementation, together with an interaction term. If the interaction was not significant, models were rerun, testing for main effects only. Intention-to-treat analysis was used, and each arsenic metabolite was tested separately. To account for potential differences in arsenic methylation due to nutritional status and growth, analyses were adjusted for BMI. As indicated above, there was no difference in findings when the models were adjusted for BMI-for-age z-score instead of BMI. Statistical significance was considered at P < .05.
Sensitivity Analyses
School water served as a proxy for household arsenic exposure. Variation in iAs concentrations in the water supply could have influenced the study results. Four schools had a ≥20% THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 185 variation in water arsenic concentration during the study period. We performed sensitivity analyses to explore the effects of this variation on trial efficacy. Each of the 4 schools with higher water arsenic concentration variability was removed from the analysis in turn, and then all were removed. These analyses were adjusted for BMI.
Results
Of the 602 children enrolled in the study, 527 completed the supplementation, and 485 children had both baseline and final UAs values (Figure; available at www.jpeds.com). Complete baseline data were available for 591 of the 602 children ( Table I) . The total UAs concentration ranged from 3.2 to 215.9 µg/L. There were sex differences in total arsenic excretion at baseline (mean ± SD: boys, 63.5 ± 35.9 µg/L; girls, 51.7 ± 28.5 µg/L; P < .01). The mean ± SD %iAs, %MMA, and %DMA values were 14.6 ± 5.3%, 13.2 ± 4.8%, and 72.4 ± 8.0%, respectively, with no sex differences. Only 12% of the study children had anemia, 11.8% had ID, and 36% had zinc deficiency ( Table I) . The supplementation groups did not differ at baseline in terms of demographic characteristics, iron or zinc status, or UAs concentration.
The mean water arsenic concentrations for the nine schools We tested the associations of %iAs, %MMA, %DMA, and total UAs concentrations with iron and zinc status indicators at baseline in the full sample. In covariate-adjusted analyses, iron and zinc deficiency were not associated with any of the UAs biomarkers, nor was anemia or serum zinc tertile (Table II) . In contrast, the highest serum ferritin tertile was associated with lower %MMA and higher %DMA (Table II) .
For the effects of supplementation, we found no iron × zinc interactions. Testing the main effects of iron and zinc supplementation revealed no differences in UAs, %iAs, or %MMA. There was no main effect of iron on %DMA, but children who received any zinc exhibited a mean 1.7 ± 0.8 decline in %DMA (P < .05; Table III ). The sensitivity analysis yielded very similar results (Table IV ; available at www.jpeds.com).
Discussion
Our finding of associations between higher serum ferritin concentration and lower %MMA and higher %DMA suggests that better iron status may promote more efficient arsenic methylation. These observational findings are not supported by the results of the randomized controlled trial, however. Therefore, providing iron or zinc supplements appears to have no effect on the metabolism of arsenic, at least in children.
A limited number of studies have examined the relationship between dietary intake or plasma concentration of iron and zinc and UAs methylation. Our findings are in direct contrast to the results of a study of Uruguayan children of similar age (5-8 years), which showed associations between serum ferritin <15 ng/mL and lower %MMA and slightly higher %DMA. Interestingly, the prevalence of ID was much higher in the Uruguayan sample (~40%), but arsenic exposure was lower (median water arsenic level <1 µg/L, compared with 9-40 µg/L in the present study). Our findings are also in contrast to those reported for the intake of iron 20 or for iron and zinc status 31 in adults. However, in another study, adults in the higher quartiles of iron and zinc intake had lower %MMA and higher %DMA in urine compared with adults with lower intake of these nutrients. 18 It is possible that iron and zinc intake were a proxy for meat consumption or overall nutritional status rather than representing iron or zinc effects on arsenic metabolism.
How iron status is related to arsenic methylation or excretion remains unclear. Iron plays no known role in the one-carbon cycle, where arsenic methylation occurs; however, iron is a good chelator of arsenic, and has been used to form insoluble compounds with iAs in water. 32, 33 Thus, there is an affinity between iron and arsenic, along with a chemical plausibility for their interaction, but this has been demonstrated in water rather the human gut and with iron salts, not dietary iron. However, it is also possible that our observational findings reflect an association of iron status with exposure from foods/environment.
Unfortunately, robust measures of dietary consumption were not collected as part of the trial, and we cannot state with confidence that this is the mechanism behind our findings.
Another important contribution of our work is the demonstration that even though iron and zinc given as supplements do not improve arsenic excretion, they also do not appear to increase the retention of arsenic in the body or its toxicity by altering the proportion of methylated arsenic metabolites found in urine. Given that micronutrient supplementation to improve nutritional status or prevent deficiencies in young children is widely recommended and practiced worldwide, this finding has important programmatic implications, showing that the metabolism of arsenic, a toxic metal, is not inadvertently perturbed by short-term supplementation. This is an important consideration for geographic regions with moderate-tohigh arsenic exposure.
Our results need to be interpreted in light of the strengths and limitations of this study. Strengths include, for the observational study, good covariate control and the inclusion of overall body size/nutritional status, which is important for arsenic metabolism as children undergo rapid growth and build muscle mass. Other strengths include the randomized controlled design, large sample size, and 91% compliance rate. Finally, we had data on UAs metabolites. Given that the methylation of arsenic and the excretion of methylated species is the primary method of detoxification, the inclusion of the metabolites provides a more complete picture of the potential effects of iron and zinc on arsenic metabolism.
A limitation of this study is the lack of data on arsenic concentrations in household water (or water intake), which was the most likely source of exposure. Nonetheless, we did have data on arsenic concentrations in municipal water delivered to all of the participating schools, and given that the water supplied to homes came from the same municipal source, we have a fairly good picture of the variation in water arsenic levels. It is possible that seasonal variations in water arsenic levels affected environmental exposure and children's excretion of arsenic in urine, and thus we attempted to account for this variation in our sensitivity analyses.
Other sources, including food, 34 could have influenced arsenic exposure. We collected rudimentary information on the children's diets at baseline, asking for the frequency of weekly consumption of major food groups. We found little correlation between the consumption of meat-eggs, dairy, fruit and vegetables, and grains-nuts and the proportions of arsenic metabolites in urine (data not shown), but perhaps this is unsurprising given the dietary measures used. An additional check for the influence of dietary sources also revealed no apparent associations; plotting %DMA against UAs (data not shown) showed no patterns indicating differential associations at low vs higher total UAs concentrations.
Another potential limitation of the study is that UAs concentrations were not adjusted for creatinine levels. The use of urinary creatinine has been questioned because creatinethe precursor of creatinine-is linked to one-carbon metabolism 35 and is a strong predictor of arsenic methylation. 36 Although creatinine or specific gravity adjustment for UAs concentrations was not available in this study, creatinine excretion has been identified as an indicator of body composition. 37 We carried out regression models adjusting for BMI, thereby accounting for some of the factors that influence creatinine levels in urine. ■ Urinary arsenic metabolite and sensitivity analysis performed Iron main effect, mean ± SE* Zinc main effect, mean ± SE*
